Lung Cancer News

January 4, 2007

CuraGen and TopoTarget Announce Presentation of Updated PXD101

Filed under: Uncategorized — admin @ 12:02 am

CuraGen and TopoTarget Announce Presentation of Updated PXD101
MSN MoneyCentral - Intravenous PXD101 is currently being evaluated in multiple clinical trials as a potential treatment for multiple myeloma, T- and B-cell lymphomas, AML, mesothelioma, liver, colorectal, ovarian cancers, either alone or in combination with anti

Facts About Asbestos
KGBT 4 - Asbestosis Lung Cancer Mesothelioma. Everyone who has ever breathed in asbestos fibers is not necessarily going to get one of these diseases. No one knows whether there is a safe level of exposure; however, the risk increases as the exposure

Rescue-dog handlers share strong bond with their canine charges
Inside Bay Area - Though doctors aren’t finding evidence of reactive airway disease, like what’s being found in people that worked the Pile, it’s thought that by studying the dogs, doctors may learn to understand a disease such as mesothelioma, a cancer caused by

W.R. Grace trial delayed until 2007
Missoulian - Mesothelioma, a rare and aggressive form of cancer that normally occurs in only nine in 1 million individuals, has been found in at least 20 of the 8,000 residents of Libby and the surrounding area, prosecutors allege in the indictment. Company

Alfacell Corporation Files for U.S. Orphan Drug Designation for
MSN MoneyCentral - Food and Drug Administration (FDA) to obtain orphan designation for its lead drug candidate ONCONASE(R) (ranpirnase) for the treatment of patients with unresectable malignant mesothelioma (UMM). ONCONASE is currently being evaluated in a

Online Press Release
PRWeb - Mesothelioma.com Finds Proposed Asbestos Bill is Taking Away Veterans’ Rights A Mesothelioma.com review of Asbestos Bill S.852 finds legislation is unfair to our nation’s Veterans of war. Unparalelled opposition is mounting on the part of Veterans

No Comments

No comments yet.

RSS feed for comments on this post.

Sorry, the comment form is closed at this time.

Powered by WordPress